Matches in Wikidata for { <http://www.wikidata.org/entity/Q64602128> ?p ?o ?g. }
Showing items 1 to 28 of
28
with 100 items per page.
- Q64602128 description "clinical trial" @default.
- Q64602128 description "ensayu clínicu" @default.
- Q64602128 description "klinisch onderzoek" @default.
- Q64602128 description "клінічне випробування" @default.
- Q64602128 name "Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q64602128 type Item @default.
- Q64602128 label "Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q64602128 prefLabel "Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder Administered Via the HandiHaler® 2 and Serevent® Diskus® in Patients With Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q64602128 P1132 Q64602128-6D42EE42-E638-4B66-9639-CB6F982A0DAE @default.
- Q64602128 P1476 Q64602128-BA2B0217-F485-418E-BDA8-AF86A77D5563 @default.
- Q64602128 P2899 Q64602128-9F01A44C-10CB-4E9A-BA10-101498DEF79B @default.
- Q64602128 P3098 Q64602128-73592548-2BC1-474E-BA08-2743F6FC5013 @default.
- Q64602128 P31 Q64602128-386AF2A2-AB1A-4CF1-A030-67336227CFDF @default.
- Q64602128 P4844 Q64602128-652CA065-9083-4C48-BE77-42A45C774E17 @default.
- Q64602128 P580 Q64602128-B6400433-81EE-490D-B1BE-4AFA78166972 @default.
- Q64602128 P582 Q64602128-12A56F4A-60BB-4FD0-8B3A-E1838AD01873 @default.
- Q64602128 P6099 Q64602128-3C1E136A-7D85-4989-84E9-2BE33E54EA42 @default.
- Q64602128 P8363 Q64602128-E08A1CCF-ECC4-4497-9D4B-C2B070008EF1 @default.
- Q64602128 P1132 "+111" @default.
- Q64602128 P1476 "A Single Dose, Placebo-controlled, Randomized, Double-blind, Double-dummy, Crossover Efficacy, Pharmacokinetics and Safety Comparison of Salmeterol Inhalation Powder (25 μg Salmeterol), Administered as the Xinafoate Salt From a Hard Polyethylene Capsule Via the HandiHaler® 2, and Serevent® Diskus® (50 μg Salmeterol) in Patients With Chronic Obstructive Pulmonary Disease (COPD)" @default.
- Q64602128 P2899 "+40" @default.
- Q64602128 P3098 "NCT02242227" @default.
- Q64602128 P31 Q30612 @default.
- Q64602128 P4844 Q27264747 @default.
- Q64602128 P580 "2005-09-01T00:00:00Z" @default.
- Q64602128 P582 "2006-02-01T00:00:00Z" @default.
- Q64602128 P6099 Q42824440 @default.
- Q64602128 P8363 Q78089383 @default.